Ultralow Dose PET Imaging of 18F-flurpiridaz
A phase 2 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 200 participants.
Also called NCT07284576
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Phase 2
- Enrolled
- 200 participants
- Sponsor
- Akiva Mintz
- Registry
-
NCT07284576
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Enrolling by invitation
Technical summary
Registry record NCT07284576. Allocation not applicable; no masking; primary purpose diagnostic. Start 2025-12-16 (actual); primary completion 2030-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ultralow Dose PET Imaging of 18F-flurpiridaz
- Condition
- Healthy Volunteer
- Condition
- Coronary Arterial Disease
- Condition
- Myocardial Ischemia
- Condition
- Myocardial Infarction
- Intervention (Drug)
- 18F-flurpiridaz
- Lead sponsor
- Akiva Mintz
Record details
- Record id
cardio:ct-nct07284576- Content hash
95eeaa8c6dc7597132f68a7b5a0588b385e79bdc97f90bd09b8c50f5cfea7db5